medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2025, Number 1

<< Back Next >>

Rev Nefrol Dial Traspl 2025; 45 (1)

Predictive Value of CAR for Renal Survival and Mortality in ICU Patients with AKI Requiring Dialysis

Kaan TA, Şahin G, Gök M, Salmanoğlu M, Çakir GB, Kaplan M

Language: English
References: 27
Page: 13-23
PDF size: 348.53 Kb.


ABSTRACT

Introduction: It has been reported that 20-60% of patients followed in the intensive care unit (ICU) develop acute kidney injury (AKI). Despite the critical care practices and different renal replacement therapies (RRT) applied in the ICU, reports indicate a high mortality rate of 50-60%. Thus, a need for a rapid, low-cost, readily accessible marker to be used in routine examinations is apparent, especially in terms of ICU mortality associated with AKI. Standard parameters used to measure inflammation and prognosis in critically ill patients are C-reactive protein (CRP) and albumin. Separately, high CRP levels and low albumin levels have been associated with poor prognosis and high mortality rates, making these two parameters welldocumented for the use of predictive markers of mortality. The ratio between these two parameters has been a novel prognostic value for numerous diseases in recent years. Objective: The present study aimed to investigate the predictive value of C-reactive protein/albumin ratio (CAR) for renal survival and mortality in ICU patients with AKI requiring dialysis. Materials and methods: This retrospective study included data from 219 (119 males,100 females) ICU patients with AKI who required dialysis. The CAR was obtained by dividing the C-reactive protein(CRP) level with the albumin level. APACHE-II scores, frequently used in intensive care units for predicting mortality, were compared with CAR’s sensitivity and specificity. The primary endpoint of the study was a composite outcome of ICU mortality. The secondary endpoint of the study was renal survival. Results: During the ICU course, 165 (75.3%) patients died. In our study, the ROC analyses showed that the CAR could be used to predict renal survival and mortality in dialysisrequiring AKI in ICU patients. CAR’s sensitivity was higher than the APACHE -II score, and the specificity was similar to predicting ICU mortality. Conclusion: To our knowledge, this is the first study to investigate CAR’s relationship with mortality and renal survival in ICU patients with acute kidney injury.


REFERENCES

  1. Matuszkiewicz-Rowińska J, Małyszko J. Acutekidney injury, its definition, and treatment inadults: guidelines and reality. Pol Arch Intern Med. 2020;130(12):1074–80.

  2. Ersan S, Köse I. The choice of renal replacementmodality in an intensive care unit: which factors arepredictive? Anatol J Gen Med Res. 2019; 29(2):162-6.

  3. Meersch M, Zarbock A. Renal replacement therapyin critically ill patients: who, when, why, and how.Curr Opin Anaesthesiol. 2018;31(2):151–7.

  4. Jones SL, Devonald MAJ. How acute kidney injuryis investigated and managed in UK intensive careunits—a survey of current practice. Nephrol DialTransplant. 2013;28(5):1186–90.

  5. Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L,Tubach F, Pons B, et al. Comparison of two strategiesfor initiating renal replacement therapy in theintensive care unit: study protocol for a randomizedcontrolled trial (AKIKI). Trials. 2015;16(1):1–9.

  6. Liu J, Wu J, Liu S, Li M, Hu K, Li K. Predictingmortality of patients with acute kidney injuryin the ICU using XGBoost model. PLoS One.2021;16(2):e0246306.

  7. Qian J, Liu L, Chu F, Shen Y, Bai X, Lu Z, et al.Association between C-reactive protein and all-causemortality among critically ill patients with acutekidney injury. Clin Nephrol. 2022;98(3):123–34.

  8. Peres LAB, Wandeur V, Matsuo T. Predictors ofacute kidney injury and mortality in an intensivecare unit. J Bras Nefrol. 2015;37(1):38–46.

  9. Abdalrahim MS, Khalil AA, Alramly M, AlshloolKN, Abed MA, Moser DK. Pre-existing chronickidney disease and acute kidney injury amongcritically ill patients. Heart Lung. 2020;49(5):626–9.

  10. Fanali G, Di Masi A, Trezza V, Marino M, FasanoM, Ascenzi P. Human serum albumin: from bench tobedside. Mol Aspects Med. 2012;33(3):209–90.

  11. Takegawa R, Kabata D, Shimizu K, Hisano S,Ogura H, Shintani A, et al. Serum albumin as a riskfactor for death in patients with prolonged sepsis: anobservational study. J Crit Care. 2019;51:139–44.

  12. Shao M, Wang S, Parameswaran PK.Hypoalbuminemia: a risk factor for acute kidneyinjury development and progression to chronickidney disease in critically ill patients. Int UrolNephrol. 2017;49:295–302.

  13. Liang Y, Xiao W, Guan YX, Wang W, Chen HY, FangC, et al. Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable softtissue sarcoma. Oncotarget. 2017;8(58):98135.

  14. Ranzani OT, Zampieri FG, Forte DN, AzevedoLCP, Park M. C-reactive protein/albumin ratiopredicts 90-day mortality of septic patients. PLoSOne. 2013;8(3):e59321.

  15. Kim MH, Ahn JY, Song JE, Choi H, Ann HW, KimJK, et al. The C-reactive protein/albumin ratio as anindependent predictor of mortality in patients withsevere sepsis or septic shock treated with early goaldirectedtherapy. PLoS One. 2015;10(7):e0132109.

  16. Kaplan M, Ates I, Akpinar MY, Yuksel M, Kuzu UB,Kacar S, et al. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis. Hepatobiliary &Pancreatic Diseases International. 2017;16(4):424–30.

  17. Güney BÇ, Taştan YÖ, Doğantekin B, Serindağ Z,Yeniçeri M, Çiçek V, et al. Predictive value of CARfor in-hospital mortality in patients with COVID-19pneumonia: a retrospective cohort study. Arch MedRes. 2021;52(5):554–60.

  18. Wang J, Zhao K, Mao X, Zhang Y, Shao J, Fan W,et al. Relationship between CRP albumin ratio andthe mortality in critically ill patients with AKI: aretrospective observational study. Biomed Res Int.2021;2021:9957563.

  19. Hoste EAJ, Clermont G, Kersten A, VenkataramanR, Angus DC, De Bacquer D, et al. RIFLE criteriafor acute kidney injury are associated with hospitalmortality in critically ill patients: a cohort analysis.Crit Care. 2006;10(3):1–10.

  20. Ricci Z, Cruz D, Ronco C. The RIFLE criteriaand mortality in acute kidney injury: a systematicreview. Kidney Int. 2008;73(5):538–46.

  21. Levey AS, James MT. Acute kidney injury. AnnIntern Med. 2017;167(9):ITC66–80.

  22. Tang Y, Huang XR, Lv J, Chung ACK, Zhang Y, ChenJZ, et al. C-reactive protein promotes acute kidneyinjury by impairing G1/S-dependent tubular epitheliumcell regeneration. Clin Sci. 2014;126(9):645–59.

  23. Pegues MA, McWilliams IL, Szalai AJ. C-reactiveprotein exacerbates renal ischemia-reperfusion injury:are myeloid-derived suppressor cells to blame? AmJ Physiol Renal Physiol. 2016;311(1):F176–81.

  24. Tang Y, Mak S, Xu AP, Lan H. Role of C‐reactiveprotein in the pathogenesis of acute kidney injury.Nephrology. 2018;23(S4):50–2.

  25. Yu M yeon, Lee SW, Baek SH, Na KY, Chae DW,Chin HJ, et al. Hypoalbuminemia at admissionpredicts the development of acute kidney injury inhospitalized patients: a retrospective cohort study.PLoS One. 2017;12(7):e0180750.

  26. Contreras AM, Ramirez M, Cueva L, AlvarezS, de Loza R, Gamba G. Low serum albumin andthe increased risk of amikacin nephrotoxicity. RevInvest Clin. 1994;46:37-43.

  27. Duarte I, Gameiro J, Resina C, Outerelo C.In-hospital mortality in elderly patients with acutekidney injury requiring dialysis: a cohort analysis.Int Urol Nephrol. 2020; 52:1117–24.




2020     |     www.medigraphic.com